These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9872340)

  • 1. Single dose pharmacokinetics of HEPP, a new anticonvulsant in normal healthy volunteers.
    González-Esquivel DF; Rubio-Donnadieu F; Carvajal-Sandoval G; Jung HC
    Biopharm Drug Dispos; 1998 Dec; 19(9):583-7. PubMed ID: 9872340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of HEPP, a new anticonvulsant, in healthy subjects and rabbits after multiple doses.
    González-Esquivel DF; Pérez RM; Cook HJ
    Biopharm Drug Dispos; 2004 Mar; 25(2):85-90. PubMed ID: 14872556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of the novel anticonvulsant HEPP after single intravenous administration of three different doses in dogs.
    Gómez LE; Lehmann PA
    Biopharm Drug Dispos; 1995 Mar; 16(2):105-12. PubMed ID: 7780044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gestational age dependency in the prenatal toxicity and in the disposition kinetics of the novel anticonvulsant HEPP (D,L-3-hydroxy-3-ethyl-3-phenylpropionamide) after subcutaneous administration in pregnant rats.
    Gómez-Martínez LE
    Int J Toxicol; 2007; 26(3):237-46. PubMed ID: 17564905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma determination of the novel anticonvulsant D,L-3-hydroxy-3-ethyl-3-phenylpropionamide and preliminary pharmacokinetic studies in the rat.
    Gomez LE; Lehmann PA
    J Chromatogr; 1992 Mar; 575(2):306-10. PubMed ID: 1629310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic interaction in rabbits between a new anticonvulsant, DL-3-hydroxy-3-ethyl-3-phenylpropionamide, and phenytoin.
    Medina L; García L; Pérez R; Fernández A; Jung H
    J Pharm Pharmacol; 1998 Dec; 50(12):1393-6. PubMed ID: 10052855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition kinetics of HEPP in rats after intravenous, oral, and intraperitoneal administration. Correlation of plasma and brain levels with the anticonvulsant effect.
    Gómez LE; Cueva-Rolón R; Lehmann PA
    Biopharm Drug Dispos; 1995 Mar; 16(2):77-89. PubMed ID: 7780049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of interaction between HEPP, a new antiepileptic agent, and carbamazepine in rabbits.
    García AL; Medina RL; Pérez MR; Jung CH
    Biopharm Drug Dispos; 2003 Jul; 24(5):205-9. PubMed ID: 12784320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of D,L-3-hydroxy-3-ethyl-3-phenylpropionamide (HEPP) in pregnant rats at different stages of gestation and maternal-fetal disposition during late pregnancy.
    Fletes Mdel R; Gómez-Martínez LE
    Reprod Toxicol; 2003; 17(2):177-84. PubMed ID: 12642150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid chromatographic assay in plasma of one of the members of a new series of anticonvulsants: D,L-3-hydroxy-3-ethyl-3-phenylpropionamide.
    Martínez de Muñoz D; Arenas R; Chávez González O
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):377-83. PubMed ID: 8738048
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of rifampicin and cimetidine on pharmacokinetics and pharmacodynamics of lamotrigine in healthy subjects.
    Ebert U; Thong NQ; Oertel R; Kirch W
    Eur J Clin Pharmacol; 2000 Jul; 56(4):299-304. PubMed ID: 10954343
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous pharmacokinetics, oral bioavailability and dose proportionality of ragaglitazar, a novel PPAR-dual activator in rats.
    Jagannath K; Chaluvadi MR; Mullangi R; Mamidi NV; Srinivas NR
    Biopharm Drug Dispos; 2004 Oct; 25(7):323-8. PubMed ID: 15386480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of dexloxiglumide after administration of single and repeat oral escalating doses in healthy young males.
    Persiani S; D'Amato M; Makovec F; Tavares IA; Bishai PM; Rovati LC
    Int J Clin Pharmacol Ther; 2002 May; 40(5):198-206. PubMed ID: 12051571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of food on the disposition of the antiepileptic oxcarbazepine and its major metabolites in healthy volunteers.
    Degen PH; Flesch G; Cardot JM; Czendlik C; Dieterle W
    Biopharm Drug Dispos; 1994 Aug; 15(6):519-26. PubMed ID: 7993989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the dose proportionality of the pharmacokinetics of sustained release sodium valproate.
    Wangemann M; Retzow A; Mazur D; Vens-Cappell B
    Int J Clin Pharmacol Ther; 2000 Aug; 38(8):395-401. PubMed ID: 10984013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and metabolism of tesaglitazar, a novel dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist, after a single oral and intravenous dose in humans.
    Ericsson H; Hamrén B; Bergstrand S; Elebring M; Fryklund L; Heijer M; Ohman KP
    Drug Metab Dispos; 2004 Sep; 32(9):923-9. PubMed ID: 15319332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant and Toxicological Evaluation of Parafluorinated/Chlorinated Derivatives of 3-Hydroxy-3-ethyl-3-phenylpropionamide.
    Garrido-Acosta O; Meza-Toledo SE; Anguiano-Robledo L; Soriano-Ursúa MA; Correa-Basurto J; Davood A; Chamorro-Cevallos G
    Biomed Res Int; 2016; 2016():3978010. PubMed ID: 27006945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of pharmacokinetics and tolerability of intranasal diazepam relative to rectal gel in healthy adults.
    Henney HR; Sperling MR; Rabinowicz AL; Bream G; Carrazana EJ
    Epilepsy Res; 2014 Sep; 108(7):1204-11. PubMed ID: 24934774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical pharmacokinetics of procaterol: dose proportionality after administration of single oral doses.
    Eldon MA; Blake DS; Coon MJ; Nordblom GD; Sedman AJ; Colburn WA
    Biopharm Drug Dispos; 1992 Dec; 13(9):663-9. PubMed ID: 1467453
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and bioequivalence study of irbesartan tablets after a single oral dose of 300 mg in healthy Thai volunteers.
    Wittayalertpanya S; Chariyavilaskul P; Prompila N; Sayankuldilok N; Eiamart W
    Int J Clin Pharmacol Ther; 2014 May; 52(5):431-6. PubMed ID: 24725445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.